Telephone-Based Acceptance and Commitment Therapy for Young Adult Hazardous Drinkers

May 26, 2026 updated by: Dr Katherine Lam, The Hong Kong Polytechnic University

A Randomized Controlled Trial of Telephone-Based Acceptance and Commitment Therapy to Assist Young Adults With Hazardous or Harmful Alcohol Use to Quit Drinking

The goal of this clinical trial is to learn if telephone-based Acceptance and Commitment Therapy (ACT) works to help young adults with hazardous or harmful alcohol use quit drinking. It will also learn about the psychological effects of ACT on participants.

The main questions it aims to answer are:

  1. Does telephone-based ACT increase the number of participants who quit drinking, as confirmed by a urine test?
  2. Does telephone-based ACT help participants reduce their alcohol consumption and improve their psychological flexibility?

Researchers will compare telephone-based ACT to a telephone-based social support programme to see if ACT works to help young adults quit drinking.

Participants will:

  1. Receive telephone-based ACT or social support once a week for 6 weeks Complete questionnaires about their alcohol use and psychological flexibility.
  2. Keep a record of their daily alcohol consumption throughout the study using a standardised diary method.
  3. Provide a urine sample at the 6-month follow-up if they report having quit drinking

Study Overview

Study Type

Interventional

Enrollment (Estimated)

226

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • (1) aged 18-35 years
  • (2) able to read Chinese and speak Cantonese
  • (3) have AUDIT scores ≥ 8

Exclusion Criteria:

  • (1) currently receiving other behavioural therapies for drinking
  • (2) has serious mental illnesses, defined as a Kessler Psychological Distress Scale score ≥ 13

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telephone-Based ACT Intervention
Telephone-based Acceptance and Commitment Therapy for participants
Participants in the intervention group will receive six weekly telephone sessions of ACT (45-60 min each) from interventionist.
Other: Telephone-Based Social Support
telephone-based social support
Participants in the control group will receive six weekly telephone sessions of social support (45 min each) from interventionist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemically-Validated Abstinence
Time Frame: T4 (6 months after the end of the intervention)
Participants who self-report quitting drinking in the past 30 days are tested for ethyl glucuronide (a by-product of alcohol metabolism) via urine strips to confirm abstinence biochemically.
T4 (6 months after the end of the intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Reported 30-Day Abstinence
Time Frame: T0 (baseline), T1 (post-intervention), T2 (1 month after the intervention), T3 (3 months after the intervention), T4 (6 months after the intervention)
Reduction in alcohol consumption and self-reported 30-day abstinence will be recorded using TLFB. Participants will be asked to report the number of drinks they have consumed within the past 30 days.
T0 (baseline), T1 (post-intervention), T2 (1 month after the intervention), T3 (3 months after the intervention), T4 (6 months after the intervention)
Reduction in Alcohol Consumption
Time Frame: T1 (post-intervention), T2 (1 month after the intervention), T3 (3 months after the intervention), T4 (6 months after the intervention)
Defined as 50% or more reduction in average alcohol consumption per day compared to baseline, measured using the Timeline Follow-Back (TLFB) questionnaire.
T1 (post-intervention), T2 (1 month after the intervention), T3 (3 months after the intervention), T4 (6 months after the intervention)
Psychological Flexibility Index
Time Frame: T0 (baseline), T1 (post-intervention), T2 (1 month after the intervention), T3 (3 months after the intervention), T4 (6 months after the intervention)
Personalised Psychological Flexibility Index(PPFI) will be used to measure psychological flexibility by 19 items rating on a 7-point scale. Higher scores represent greater psychological flexibility. It has been validated among Chinese college students
T0 (baseline), T1 (post-intervention), T2 (1 month after the intervention), T3 (3 months after the intervention), T4 (6 months after the intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

August 1, 2029

Study Completion (Estimated)

August 1, 2029

Study Registration Dates

First Submitted

May 26, 2026

First Submitted That Met QC Criteria

May 26, 2026

First Posted (Actual)

June 2, 2026

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

May 26, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hazardous Drinking

Clinical Trials on Telephone-Based Acceptance and Commitment Therapy (ACT)

Subscribe